Product Program year 2025 Source: CMS Open Payments

Accu-Chek Guide

Device Diabetes Care

PDI 00365702609105

Open in the dashboard

General payments

$8,698

17 payments

Research payments

$4,699,321

88 payments

Through program year 2025, $8,698 in general payments and $4,699,321 in research payments were reported against Accu-Chek Guide (Diabetes Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 Research $3,779,031 35
2024 General $8,660 15
2024 Research $496,214 42
2023 Research $156,140 1
2022 Research $103,272 4
2021 General $38 2
2021 Research $164,665 6

Breakdown

Who paid General payments · program years 2021–2024
  1. Roche Diabetes Care, Inc. $8,698 17 payments
Top recipients General payments · program year 2024
  1. Melissa Katz Endocrinology, Diabetes & Metabolism · New York, NY $777 9% · 1 payment
  2. Alan Dresner Endocrinology, Diabetes & Metabolism · West Nyack, NY $777 9% · 1 payment
  3. Chithranjan Nath Endocrinology, Diabetes & Metabolism · Fishkill, NY $777 9% · 1 payment
  4. Alina Gouller Endocrinology, Diabetes & Metabolism · New York, NY $777 9% · 1 payment
  5. Yevgeniy Kantor Endocrinology, Diabetes & Metabolism · Brooklyn, NY $777 9% · 1 payment

The top 5 of 15 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $5,751 66% · 8 practitioners
  2. Internal Medicine $1,096 13% · 2 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $677 8% · 2 practitioners
  4. Family Medicine $500 6% · 1 practitioner
  5. Nurse Practitioner $318 4% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $4,782 55% · 7 recipients
  2. Massachusetts $3,598 42% · 7 recipients
  3. California $280 3% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

17 general · 88 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record